Literature DB >> 33706250

Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.

Eileanoir B Johnson1, Christopher S Parker2, Rachael I Scahill3, Sarah Gregory3, Marina Papoutsi4, Paul Zeun3, Katherine Osborne-Crowley5, Jessica Lowe3, Akshay Nair6, Carlos Estevez-Fraga3, Kate Fayer3, Geraint Rees7, Hui Zhang2, Sarah J Tabrizi8.   

Abstract

BACKGROUND: Pathological processes in Huntington's disease (HD) begin many years prior to symptom onset. Recently we demonstrated that in a premanifest cohort approximately 24 years from predicted disease onset, despite intact function, there was evidence of subtle neurodegeneration. Here, we use novel imaging techniques to determine whether macro- and micro-structural changes can be detected across the whole-brain in the same cohort.
METHODS: 62 premanifest HD (PreHD) and 61 controls from the HD Young Adult Study (HD-YAS) were included. Grey and white matter volume, diffusion weighted imaging (DWI) measures of white matter microstructure, multiparametric maps (MPM) estimating myelin and iron content from magnetization transfer (MT), proton density (PD), longitudinal relaxation (R1) and effective transverse relaxation (R2*), and myelin g-ratio were examined. Group differences between PreHD and controls were assessed; associations between all imaging metrics and disease burden and CSF neurofilament light (NfL) were also performed. Volumetric and MPM results were corrected at a cluster-wise value of familywise error (FWE) 0.05. Diffusion and g-ratio results were corrected via threshold-free cluster enhancement at FWE 0.05.
FINDINGS: We showed significantly increased R1 and R2*, suggestive of increased iron, in the putamen, globus pallidum and external capsule of PreHD participants. There was also a significant association between lower cortical R2*, suggestive of reduced myelin or iron, and higher CSF NfL in the frontal lobe and the parieto-occipital cortices. No other results were significant at corrected levels.
INTERPRETATION: Increased iron in subcortical structures and the surrounding white matter is a feature of very early PreHD. Furthermore, increases in CSF NfL were linked to microstructural changes in the posterior parietal-occipital cortex, a region previously shown to undergo some of the earliest cortical changes in HD. These findings suggest that disease related process are occurring in both subcortical and cortical regions more than 20 years from predicted disease onset.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Huntington's disease; Iron; MRI; Microstructure; Myelin

Year:  2021        PMID: 33706250      PMCID: PMC7960938          DOI: 10.1016/j.ebiom.2021.103266

Source DB:  PubMed          Journal:  EBioMedicine        ISSN: 2352-3964            Impact factor:   8.143


  56 in total

1.  Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease.

Authors:  J M G van Bergen; J Hua; P G Unschuld; I A L Lim; C K Jones; R L Margolis; C A Ross; P C M van Zijl; X Li
Journal:  AJNR Am J Neuroradiol       Date:  2015-12-17       Impact factor: 3.825

2.  Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically.

Authors:  Sonal Agrawal; Julia Fox; Baskaran Thyagarajan; Jonathan H Fox
Journal:  Free Radic Biol Med       Date:  2018-04-04       Impact factor: 7.376

3.  Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

Authors:  J L Whitwell; W R Crum; H C Watt; N C Fox
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

4.  Elevated brain iron is independent from atrophy in Huntington's Disease.

Authors:  Eve M Dumas; Maarten J Versluis; Simon J A van den Bogaard; Matthias J P van Osch; Ellen P Hart; Willeke M C van Roon-Mom; Mark A van Buchem; Andrew G Webb; Jeroen van der Grond; Raymund A C Roos
Journal:  Neuroimage       Date:  2012-03-28       Impact factor: 6.556

5.  Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Authors:  Kevin Michael Biglan; Ira Shoulson; Karl Kieburtz; David Oakes; Elise Kayson; M Aileen Shinaman; Hongwei Zhao; Megan Romer; Anne Young; Steven Hersch; Jack Penney; Karen Marder; Jane Paulsen; Kimberly Quaid; Eric Siemers; Caroline Tanner; William Mallonee; Greg Suter; Richard Dubinsky; Carolyn Gray; Martha Nance; Scott Bundlie; Dawn Radtke; Sandra Kostyk; Corrine Baic; James Caress; Francis Walker; Victoria Hunt; Christine O'Neill; Sylvain Chouinard; Stewart Factor; Timothy Greenamyre; Cathy Wood-Siverio; Jody Corey-Bloom; David Song; Guerry Peavy; Carol Moskowitz; Melissa Wesson; Ali Samii; Thomas Bird; Hillary Lipe; Karen Blindauer; Frederick Marshall; Carol Zimmerman; Jody Goldstein; Diana Rosas; Peter Novak; John Caviness; Charles Adler; Amy Duffy; Vicki Wheelock; Teresa Tempkin; David Richman; Lauren Seeberger; Roger Albin; Kelvin L Chou; Brad Racette; Joel S Perlmutter; Susan Perlman; Yvette Bordelon; Wayne Martin; Marguerite Wieler; Blair Leavitt; Lynn Raymond; Joji Decolongon; Lorne Clarke; Joseph Jankovic; Christine Hunter; Robert A Hauser; Juan Sanchez-Ramos; Sarah Furtado; Oksana Suchowersky; Mary Lou Klimek; Mark Guttman; Rustom Sethna; Andrew Feigin; Marie Cox; Barbara Shannon; Alan Percy; Leon Dure; Madaline Harrison; William Johnson; Donald Higgins; Eric Molho; Constance Nickerson; Sharon Evans; Douglas Hobson; Carlos Singer; Nestor Galvez-Jimenez; Kathleen Shannon; Cynthia Comella; Christopher Ross; Marie H Saint-Hilaire; Claudia Testa; Adam Rosenblatt; Penelope Hogarth; William Weiner; Peter Como; Rajeev Kumar; Candace Cotto; Julie Stout; Alicia Brocht; Arthur Watts; Shirley Eberly; Christine Weaver; Tatiana Foroud; James Gusella; Marcy MacDonald; Richard Myers; Stanley Fahn; Clifford Shults
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

6.  An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging.

Authors:  Jesper L R Andersson; Stamatios N Sotiropoulos
Journal:  Neuroimage       Date:  2015-10-20       Impact factor: 6.556

7.  Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.

Authors:  Francesca Bagnato; Simon Hametner; Emma Boyd; Verena Endmayr; Yaping Shi; Vasiliki Ikonomidou; Guanhua Chen; Siddharama Pawate; Hans Lassmann; Seth Smith; E Brian Welch
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

8.  Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.

Authors:  Emilie Lommers; Jessica Simon; Gilles Reuter; Gaël Delrue; Dominique Dive; Christian Degueldre; Evelyne Balteau; Christophe Phillips; Pierre Maquet
Journal:  Neuroimage Clin       Date:  2019-05-29       Impact factor: 4.881

9.  Huntington's disease alters human neurodevelopment.

Authors:  Mariacristina Capizzi; Esther Aparicio; Monia Barnat; Susana Boluda; Doris Wennagel; Radhia Kacher; Rayane Kassem; Sophie Lenoir; Fabienne Agasse; Barbara Y Braz; Jeh-Ping Liu; Julien Ighil; Aude Tessier; Scott O Zeitlin; Charles Duyckaerts; Marc Dommergues; Alexandra Durr; Sandrine Humbert
Journal:  Science       Date:  2020-07-16       Impact factor: 47.728

10.  Quantitative multi-parameter mapping of R1, PD(*), MT, and R2(*) at 3T: a multi-center validation.

Authors:  Nikolaus Weiskopf; John Suckling; Guy Williams; Marta M Correia; Becky Inkster; Roger Tait; Cinly Ooi; Edward T Bullmore; Antoine Lutti
Journal:  Front Neurosci       Date:  2013-06-10       Impact factor: 4.677

View more
  3 in total

1.  Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra-strong gradient MRI.

Authors:  Chiara Casella; Maxime Chamberland; Pedro L Laguna; Greg D Parker; Anne E Rosser; Elizabeth Coulthard; Hugh Rickards; Samuel C Berry; Derek K Jones; Claudia Metzler-Baddeley
Journal:  Hum Brain Mapp       Date:  2022-04-09       Impact factor: 5.399

2.  Huntington's Disease Gene Hunters: An Expanding Tale.

Authors:  Anne E Rosser; Lesley Jones
Journal:  Mov Disord Clin Pract       Date:  2021-12-16

3.  Alterations in metal homeostasis occur prior to canonical markers in Huntington disease.

Authors:  Anna C Pfalzer; Yan Yan; Hakmook Kang; Melissa Totten; James Silverman; Aaron B Bowman; Keith Erikson; Daniel O Claassen
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.